Subscribe to learn more about biologics drug development and more...

Learn how our insights and latest advancements can drive success in your field

 

 

Reliable solutions to support you at every step

Your end-to-end biologics workflow 

The use of biological products is expanding rapidly in the prevention, diagnosis, and treatment of a range of health conditions. From peptides and enzymes to viral vaccines and gene therapy vectors, your breakthroughs can change lives. But as demands grow across academic and industrial settings, your lab must ensure stability, kinetics, aggregation, and binding issues are caught early, before they become a late-stage problem at scale. 

Empower your biologics workflow with instruments for every stage from Malvern Panalytical.

 

 


By submitting this form you will receive be opting in to receive marketing communications from Malvern Panalytical. For more information please read our Privacy Policy. You can unsubscribe at any time by clicking the unsubscribe link found in the footer of our marketing emails.

 

Complete protein characteristics

 

Whether you're working in discovery, formulation, process development, or QC, you need consistent, reproducible, and scalable data to take you smoothly to the finish line. Get high-quality insights into size, stability, aggregation, kinetics, and more, to make better decisions with less rework, lower cost of ownership, and more scalable throughput.  

 

Each instrument in our portfolio answers a critical question:  

 

  • Is my molecule stable? 
  • Is it binding as expected? 
  • Is it aggregated or heterogeneous? 
  • Is it expressed and optimized efficiently? 


 

The cost of late-stage instability​ 

 

How much late-stage risk is hidden in inconsistent/unreliable early stability data?​ Smarter early decisions reduce downstream failure and shorten time to a viable biologics program. 

 

Our biologics tools help you: 

 

  • Find the right candidate faster in early development  
  • De-risk stability before it becomes a problem  
  • Resolve heterogeneity in pre-clinical development  
  • Select the most stable biotherapeutic candidate for developability 
  • Build your formulation around stability 

 

Deep stability insights. High-quality data at scale. Faster biologics development. 

 

We've been a leading provider of analytical solutions to the pharmaceutical industry for over 50 years, with instruments used in leading university and industrial labs worldwide.  

 

When your data needs to hold up to regulatory scrutiny, peer review, and cross-site reproducibility, our instruments deliver. 

Our experts insights